Prion Protein Misfolding and Brain Degeneration

Author(s): Claudio Hetz, Sergio Benavent, Sylvain Bieler, Claudio Soto

Journal Name: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Continued as Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry

Volume 3 , Issue 2 , 2003

Abstract:

Prion diseases are rare fatal neurodegenerative diseases of humans and other animals. The hallmark pathological features of TSEs are the spongiform degeneration of the brain, extensive neuronal loss, astrogliosis, and accumulation in the brain of a misfolded form of the prion protein (PrP). It has been proposed that PrP conformational changes may lead to the loss of physiological function of PrP or to acquisition of a neurotoxic activity by the misfolded protein, which may promote directly neuronal dysfunction. Alternatively, misfolded and aggregated prion protein may cause disease by inducing a chronic inflammatory reaction in the brain, leading to extensive brain damage mediated by reactive astrocytes and activated microglia. The aim of this article will be to review the different mechanisms that could relate PrP misfolding with brain degeneration and the emergence of TSE.

Keywords: prion protein misfolding, brain degeneration, astrogliosis, neurotoxic activity

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 3
ISSUE: 2
Year: 2003
Page: [137 - 147]
Pages: 11
DOI: 10.2174/1568013033483519
Price: $58

Article Metrics

PDF: 2